(S)-2-Amino-3-(2-(2-carboxyethyl)-4-(3-nitrobenzamido)phenyl)propanoic acid

ID: ALA3337650

Chembl Id: CHEMBL3337650

PubChem CID: 118714813

Max Phase: Preclinical

Molecular Formula: C19H19N3O7

Molecular Weight: 401.38

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  N[C@@H](Cc1ccc(NC(=O)c2cccc([N+](=O)[O-])c2)cc1CCC(=O)O)C(=O)O

Standard InChI:  InChI=1S/C19H19N3O7/c20-16(19(26)27)10-12-4-6-14(8-11(12)5-7-17(23)24)21-18(25)13-2-1-3-15(9-13)22(28)29/h1-4,6,8-9,16H,5,7,10,20H2,(H,21,25)(H,23,24)(H,26,27)/t16-/m0/s1

Standard InChI Key:  UVWRLBXLBJBSEP-INIZCTEOSA-N

Alternative Forms

1. Parent:

   

   ALA3337650

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 401.38

Molecular Weight (Monoisotopic): 401.1223

AlogP: 1.82

#Rotatable Bonds: 9

Polar Surface Area: 172.86

Molecular Species: ZWITTERION

HBA: 6

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 10

HBD (Lipinski): 5

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 1.70

CX Basic pKa: 9.44

CX LogP: -0.15

CX LogD: -3.34

Aromatic Rings: 2

Heavy Atoms: 29

QED Weighted: 0.36

Np Likeness Score: -0.59

References

1. Sköld N, Nielsen B, Olsen J, Han L, Olsen L, Madsen U, Kristensen JL, Pickering DS, Johansen TN..  (2014)  Design, synthesis and in vitro pharmacology of GluK1 and GluK3 antagonists. Studies towards the design of subtype-selective antagonists through 2-carboxyethyl-phenylalanines with substituents interacting with non-conserved residues in the GluK binding sites.,  22  (19): [PMID:25172149] [10.1016/j.bmc.2014.07.045]

Source

Source(1):

• Scientific Literature